Company intelligence / Profile preview

Neurocon

Ilmenau, Thuringia, Germany

Ownership: Private
Employees: ~50
Development stage: Other

Overview

neuroConn is a leading German medical technology company specializing in non-invasive brain stimulation (NIBS) and EEG technology. As a subsidiary of the neuroCare Group, the company develops and manufactures advanced systems for transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), and high-performance EEG/ERP recording. Its flagship products, such as the DC-STIMULATOR and NEURO PRAX, are widely used in both clinical research and therapeutic practice for treating conditions like depression, chronic pain, and stroke-related impairments. neuroConn is recognized for its commitment to precision, safety, and the integration of neuromodulation with personalized mental health care.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

The City College of New YorkFraunhofer-Gesellschaft

Beyond the preview

Go deeper on Neurocon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurocon.

Explore the full profile